Table 2 |
|||
|
Adjusted risks of outcomes associated with the hepatitis coinfection* |
|||
|
Outcome |
Ratio or coefficient |
95% confidence interval |
p |
|
|
|||
|
Hepatotoxicity |
|||
|
Grade ≥2† |
2.94 |
1.49-5.81 |
0.002 |
|
Grade ≥3† |
2.18 |
0.61-7.75 |
0.2 |
|
Highest grade‡ |
1.83 |
1.28-2.60 |
0.001 |
|
CD4 cell count increase|| |
|||
|
Primary slope |
0.02 |
-0.20 to 0.24 |
0.9 |
|
Secondary slope¶ |
-0.04 |
-0.38 to 0.31 |
0.8 |
|
Quadratic effect¶ |
0.00 |
-0.00 to 0.01 |
0.8 |
|
Viral load < 400 copies/mL† |
1.00 |
0.68-1.47 |
0.9 |
|
Death† |
0.52 |
0.14-1.93 |
0.3 |
|
Death or new AIDS-defining event† |
0.37 |
0.11-1.29 |
0.1 |
|
|
|||
|
* Coinfected patients versus monoinfected patients. † Cox regression. ‡ Poisson regression. || Mixed-effect linear regression of the square root-transformed CD4 cell count. ¶ From 6 months to 24 months, combined with the primary slope. |
|||
|
Mbougua et al. BMC Public Health 2010 10:105 doi:10.1186/1471-2458-10-105 |
|||